Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00513578
Status:
UNKNOWN
Last Update Posted:
2014-01-06
First Post:
2007-08-06
Brief Title:
Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome
Sponsor:
The Vaccine Company
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndromes |